Week 4 Flashcards
1
Q
Objectives of Immunization Programs
A
- Prevent, control, eliminate, eradicate vaccine preventable diseases
- By directly protecting vaccine recipients and indirectly protecting vulnerable peoples
2
Q
Vaccination Definition
A
Intentional exposure to pathogens in a form that cannot cause infectious disease
3
Q
Vaccine Purpose
A
Recipient to develop long-term immune protection against pathogen
4
Q
Benjamin Jesty
A
- Inoculated family with pus from cowpox blister of a cow
- Protect from smallpox
- Fear of wife & children becoming victims of smallpox
- Never published results
5
Q
Edward Jenner
A
- Demonstrated immunity to smallpox
- Inoculating 8 year old body with cowpox virus
- Boy did not acquire disease
6
Q
Smallpox Vaccine Significance
A
- First & only procedure that has fully eliminated & eradicated the disease as of 1980
- Vaccine no longer needed
7
Q
Louis Pasteur
A
- Created vaccines against chicken cholera, anthrax, rabis
- Isolate, inactivate using heat & inject
- First to propose germ theory of disease
8
Q
Tetanus
A
- Leads to general rigidity and convulsive spasms
- Death rate 10% of cases
9
Q
Measles
A
- Causes bronchopneumonia - 1 in 10 cases
- Encephalitis (15% fatal) - 1 in 1000 cases
10
Q
Rubella
A
- Mild disease
- Encephalitis - 1 in 6000 cases
- Congenital rubella syndrome - during pregnancy
11
Q
Cost
A
- Savings in health costs
- Immunization program cost less than treating disease
12
Q
Andrew Wakefield
A
- Claimed MMR vaccine causes autism in 1998
- Vaccination rates dropped
- Retracted Feb 2000 - no link between MMR & autism
- One of the most serious fraud in medical history
13
Q
Herd Immunity
A
- Protects susceptible individuals by stopping transmission
- Risk of infection reduced when # of individuals who can spread pathogen is reduced
14
Q
Sustained Transmission
A
- Transmitting case
- Susceptible
- Transmitting case
- Susceptible
15
Q
Transmission Terminated
A
- Transmitting case
- Immune
- Susceptible indirectly protected
16
Q
Herd Immunity Effectiveness
A
- Sufficient # of people must be immune
- Depends on transmissibility of infectious agent
17
Q
Vaccine Efficacy
A
Ability of vaccine to prevent illness in vaccinated people within a controlled study
18
Q
Vaccine Effectiveness
A
Vaccine’s ability to prevent illness in the real world
19
Q
Reproduction Number R0
A
- Average # of transmissions expected of a single case when introduced into susceptible population
- Highly infectious = high R0 rate (measles)
20
Q
Disease Outbreaks
A
Can occur when immunity falls below a critical % in a population
21
Q
Vaccine Hesitancy
A
Delay in acceptance/refusal of vaccination despite availability of vaccine services
22
Q
Vaccine Exemptions
A
- Medical - previously infected, condition preventing vaccine
- Non-medical - philosophical, religious
23
Q
Vaccines with High Hesitancy
A
- MMR
- HPV
- Covid-19
24
Q
Calculation
A
- Individuals engagement in extensive information searching
- Time & ability to search for information to make decision
25
Q
Collective Responsibility
A
- Willingness to protect other by one’s own vaccination
- Community (herd) immunity
26
Q
Confidence
A
- Trust in effectiveness/safety of vaccines
- Reliability & competences of healthcare services
- Motivation of policy makers who decide on vaccines
27
Q
Convenience
A
- Physical availability
- Ability to comprehend vaccine information/health literacy
- Appeal of immunization services to effect uptake
28
Q
Complacency
A
- Perceived risk of vaccine preventable diseases is low
- Vaccination not deemed necessary to prevent disease
29
Q
Immunizing Agents
A
- Active or passive
- Depending on process which they confer immunity
30
Q
Passive Immunization
A
- Transfer of preformed antibodies from one person to another
- Provide immediate temporary infection
- Reducing severity of illness caused by infectious agent
- Transferred antibodies degrade overtime
31
Q
Passive Immunization Purpose
A
- Transplacental transfer up to 1 year
- Provide protection when active vaccine not available
- Rapid protection required post exposure
32
Q
Acute Immunization
A
- Stimulation of immune system to produce specific antibodies - immunologic memory
- Lasts for many years or lifetime
- Survive infection of disease causing form of organism
- Vaccination can also create immunologic memory
33
Q
Active Immunity
A
- Natural infection
- Artificial vaccination
34
Q
Passive Immunity
A
- Natural maternal antibodies
- Artificial monoclonal antibodies
35
Q
How Vaccines Work
A
- Biological product designed to induced safe immune response
- Weakened/killed form of disease injected into body
- Body creates antibodies to fight the germs
- If the actual disease germs ever attack the body the antibodies destroy them
36
Q
Ideal Vaccine
A
- Safe - low risk of adverse effects
- Effective in providing lifelong protection
- Inexpensive
- Stable during shipping & storage
- Easy to administer
37
Q
Inactivated Vaccines - Whole
A
- Cannot cause disease meant to prevent due to virus being dead
- Bacteria modified to remove pathogenic response
- Immune response less than live vaccines
- Multiple doses
- Primary vaccination - prime immune system
- Booster doses may be required to boost antibody levels
38
Q
Subunit Inactivated Vaccines
A
- Toxoid
- Polysaccharide-based (pure, conjugate)
- Use specific pieces of germ
39
Q
Live Attenuated Vaccines
A
- Attenuated (weakened) form of wild virus/bacterium
- Must replicate/grow within person to produce immune response
- Immune response identical to natural infection
- Produce immunity with 1 dose (excludes oral admin)
- 2nd dose ensures almost all recipients protected
- Severe reactions possible - contraindicated in immune compromised individuals
- Fragile store carefully
40
Q
Under Attenuated
A
- Cause disease
- Bacteria not weakened enough
41
Q
Over Attenuated
A
Does not provoke enough immune response
42
Q
Inactivated Vaccine Microbes
A
- Cannot be attenuated
- Have oncogenic potential
43
Q
Polysaccharide Vaccines
A
- Inactive
- Sugar molecule chains
- T cell independent response
- Stimulate B cells without T helper cells
- Young children don’t respond consistently due to immune system immaturity
- Repeat doses do not cause booster response - IgM mainly produced
44
Q
Conjugation
A
- Polysaccharide combined with protein molecule
- Changes immune response to T cell dependent
- Antibody booster response to multiple doses
45
Q
Pure Polysaccharide Examples
A
- Pneumococcal
- Meningococcal
- Salmonella typhi (Vi)
46
Q
Conjugate Polysaccharide Examples
A
- Haemophilus influenzae type b (Hib)
- Pneumococcal
- Meningococcal
47
Q
Toxoid Vaccines
A
- Use toxin (harmful product) made by germ
- Create immunity to parts of germ that cause disease not whole germ
- Protein based toxin is harmless & used as antigen in vaccine to create immunity
- Toxin converted to toxoid with heat/chemicals
- Toxin absorbed by aluminium/chemical salts
- Antigens remain intact
- Cannot cause disease they prevent
- Vaccine antigens not actively multiplying
- Stable - no response to temp, light
- Require several doses
- Need adjuvants - not highly immunogenic on own
48
Q
mRNA Vaccines in Canada
A
Pfizer & moderna COVID-19 vaccines
49
Q
Katalin Kariko
A
- Hungarian biochemist
- PHD in biology
- Denied funding in mRNA many times
- Senior VP develop Pfizer
50
Q
How mRNA Works
A
- Change instructions of body to build a defense against virus
- Technology creates mRNA sequence that body recognizes as if its own cells
- Lipid nanoparticle system to deliver mRNA to dendritic cell
- Stays in cytoplasm
- Ribosomes read instructions & manufacture protein
- Dendritic cells place proteins on surface
- Travels to nearby lymph node to present surface protein to other cells of immune system
- Helper T cells communicate with B cells to develop antibodies that fit onto protein
- B cells then produce antibodies to identify & neutralize
- Survives 1-3 days
- Cellular enzymes breakdown RNA once used
51
Q
mRNA Structure
A
- Single strand molecule
- No thiamine
52
Q
mRNA Vaccine Advantages
A
- Easier & safer to produce than vaccines that require weak/inactive pathogen
- Easily altered for protein spikes/common viral mutations
53
Q
mRNA Vaccine Disadvantages
A
- Challenge to deliver to cells as innate immune system can destroy (use lipid nanoparticles to protect mRNA)
- Lipid nanoparticles require uninterrupted freezing/refrigeration - easily damaged (stick protocols for transport & delivery)
54
Q
Future of mRNA Vaccines
A
- Likely many more to come
- Further work on stabilization methods to ease transport & admin
- Limitless possibilities for protection against pathogens
- Personalized vaccine to targeting genetic mutations in cancer cells
